Search Results 1041-1050 of 18054 for multiple%20sclerosis
The purpose of this study is to identify patient factors that are associated with low-viability or low-dose out-of specification (OOS) in ciltacabtagene ...
Rochester, Minn. The goals of the study are to prospectively evaluate clinical and laboratory biomarkers of multiple system atrophy and Parkinson's disease at ...
The purpose of this study is to determine the overall response rate (ORR) of utilizing elotuzumab, pomalidomide and dexamethasone in patients with multiple ...
Root Cause of Multiple Myeloma Relapse Revealed. Dana Sparks. September 18 ... August 20, 2013. First · Previous ... 344 · 345 · 346 · 347 · 348 · 349 · 350 ...
... multiple. Cancer. Research shows new treatment could delay cancer progression in patients with high-risk smoldering multiple myeloma ... 20 · 21 · 22 · 23 · 24 ...
Being farsighted or having certain diseases — such as diabetes, multiple sclerosis ... 20, 2021. Print. Show references. Mian SI. Visual impairment in adults ...
The purpose of this study is to develop a natural history dataset and biorepository of early Primary Lateral Sclerosis (PLS) and well-established PLS cases for ...
The promise of plasma biomarkers to identify early pathology is growing rapidly (Palmqvist et al, 2020), however it is likely that multiple converging ...
Center for Multiple Sclerosis and Autoimmune Neurology · Center for Regenerative Biotherapeutics · Children's Research Center · Clinical Immunology and ...
Cutaneous Nodules and Inflammatory Arthritis: Two ... The Effectiveness of Sacubitril/Valsartan in Systemic Sclerosis Patients with Heart Failure: A Retrospective ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.